Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MALCOLM T FOSTER

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1861482556
CMS profile
84544
Location
KNOXVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$52,510.78

156 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MALCOLM T FOSTER

NPI 1861482556 · CMS profile ID 84544

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

KNOXVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1861482556?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MALCOLM T FOSTER, NPI 1861482556, CMS profile ID 84544. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1861482556?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MALCOLM T FOSTER, NPI 1861482556, CMS profile ID 84544. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1861482556?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MALCOLM T FOSTER, NPI 1861482556, CMS profile ID 84544, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1861482556?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

156 matching records · $52,510.78 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 156 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 156.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $6.6305/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658590467 CMS
Penumbra, Inc. $483.7305/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702917135 CMS
Penumbra, Inc. $162.3205/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702918327 CMS
Penumbra, Inc. $152.3205/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702919339 CMS
Boston Scientific Corporation $100.1805/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663304495 CMS
ABIOMED $145.7205/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676727129 CMS
Merit Medical Systems Inc $408.1604/27/2019 Royalty or License No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697819383 CMS
Janssen Pharmaceuticals, Inc $5.6804/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658590447 CMS
Cardiovascular Systems Inc. $15.9304/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702249715 CMS
Regeneron Healthcare Solutions, Inc. $13.5704/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673378695 CMS
SANOFI-AVENTIS U.S. LLC $19.5404/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694030945 CMS
Abbott Laboratories $6.2204/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667308657 CMS
BIOTRONIK INC. $16.8604/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701543531 CMS
Amgen Inc. $13.5704/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663269433 CMS
Boston Scientific Corporation $11.8404/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663304464 CMS
ConvaTec Inc. $15.4204/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700354931 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $9.2803/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625187245 CMS
PFIZER INC. $12.1903/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673750407 CMS
Amarin Pharma Inc. $97.8903/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699109943 CMS
Amarin Pharma Inc. $21.2603/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699109953 CMS
Cardinal Health 200, LLC $12.3203/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658964569 CMS
Janssen Pharmaceuticals, Inc $18.3003/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658590391 CMS
Amarin Pharma Inc. $128.3603/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699100957 CMS
Amarin Pharma Inc. $2,237.5003/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699098123 CMS
Amarin Pharma Inc. $3,250.0003/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699099371 CMS
Amarin Pharma Inc. $2,237.5003/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699099423 CMS
Cardiovascular Systems Inc. $8.9703/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702250367 CMS
Abbott Laboratories $14.4802/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 664587125 CMS
Actelion Pharmaceuticals US, Inc. $15.5602/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659743081 CMS
Janssen Pharmaceuticals, Inc $19.5602/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658590353 CMS
Boston Scientific Corporation $14.2802/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663304475 CMS
Abbott Laboratories $2,500.0002/25/2019 Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665911995 CMS
Novartis Pharmaceuticals Corporation $23.2702/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660097504 CMS
Abbott Laboratories $5.1602/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667300961 CMS
Abbott Laboratories $22.3402/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667300967 CMS
Cardinal Health 200, LLC $69.0502/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658964563 CMS
Merit Medical Systems Inc $169.2802/02/2019 Royalty or License No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697819391 CMS
Janssen Pharmaceuticals, Inc $14.6001/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658590295 CMS
Novartis Pharmaceuticals Corporation $21.7201/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660097529 CMS
Boston Scientific Corporation $13.9401/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663304469 CMS
Gilead Sciences, Inc. $14.4901/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681513109 CMS
Abbott Laboratories $103.4601/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667299321 CMS
Amarin Pharma Inc. $105.0001/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699055409 CMS
Amarin Pharma Inc. $3,800.0001/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699057037 CMS
Amarin Pharma Inc. $164.8501/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699061915 CMS
Amarin Pharma Inc. $307.4501/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699063525 CMS
Amarin Pharma Inc. $80.0001/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699063673 CMS
Amarin Pharma Inc. $769.0001/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699065277 CMS
Amarin Pharma Inc. $80.0001/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699065321 CMS
Amarin Pharma Inc. $24.0001/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699066785 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $52,510.78 156
PY2020 $36,048.32 112
PY2021 $35,374.47 136
PY2022 $55,448.54 192
PY2023 $57,251.00 187
PY2024 $86,687.91 220
PY2025 $89,966.40 201

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,258.68 27
PY2024 Principal investigator $164,394.91 44
PY2023 Principal investigator $229,275.57 52
PY2022 Principal investigator $221,161.77 67
PY2021 Principal investigator $121,455.06 150
PY2020 Principal investigator $270,116.39 147
PY2019 Principal investigator $397,562.72 150

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $2,448.00 12/12/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272892
Principal investigator 1 Penumbra, Inc. $851.50 12/11/2025 Non-covered Recipient Entity
Metro Knoxville HMA, LLC
STRIKE-PE No dispute reported 06/30/2026 1172010612
Principal investigator 1 Janssen Research & Development, LLC $2,864.00 11/19/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272971
Principal investigator 1 Penumbra, Inc. $985.40 11/14/2025 Non-covered Recipient Entity
Metro Knoxville HMA, LLC
STRIKE-PE No dispute reported 06/30/2026 1172010610
Principal investigator 1 Janssen Research & Development, LLC $5,885.00 11/07/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272962
Principal investigator 1 Abbott Laboratories $1,920.00 11/03/2025 Non-covered Recipient Entity
Tennova Healthcare-Turkey Creek Medical Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248158986
Principal investigator 1 Janssen Research & Development, LLC $416.00 11/03/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272666
Principal investigator 1 Penumbra, Inc. $2,486.90 10/15/2025 Non-covered Recipient Entity
Metro Knoxville HMA, LLC
STRIKE-PE No dispute reported 06/30/2026 1171902656
Principal investigator 1 Janssen Research & Development, LLC $955.00 09/19/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272659
Principal investigator 1 Abbott Laboratories $354.00 09/18/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT03309332--AMPLATZER PFO Occluder Post Approval Study No dispute reported 06/30/2026 1248156728
Principal investigator 1 Penumbra, Inc. $3,310.80 09/14/2025 Non-covered Recipient Entity
Metro Knoxville HMA, LLC
STRIKE-PE No dispute reported 06/30/2026 1171902654
Principal investigator 1 Janssen Research & Development, LLC $1,464.00 08/25/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272683
Principal investigator 1 Abbott Laboratories $310.00 08/04/2025 Non-covered Recipient Entity
Tennova Healthcare-Turkey Creek Medical Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248154852
Principal investigator 1 Penumbra, Inc. $9,500.00 07/24/2025 Non-covered Recipient Entity
Metro Knoxville HMA, LLC
STRIKE-PE No dispute reported 06/30/2026 1171902652
Principal investigator 1 Janssen Research & Development, LLC $9,130.00 07/23/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Turkey Crk Medcl
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272782
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,947.48 06/30/2025 Non-covered Recipient Entity
TURKEY CREEK MEDICAL CENTER
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190301965
Principal investigator 1 Janssen Research & Development, LLC $2,357.00 06/23/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175273002
Principal investigator 1 Janssen Research & Development, LLC $6,120.00 06/20/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175273099
Principal investigator 1 Janssen Research & Development, LLC $1,224.00 05/21/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175273081
Principal investigator 1 Abbott Laboratories $200.00 05/14/2025 Non-covered Recipient Entity
Tennova Healthcare-Turkey Creek Medical Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248150926
Principal investigator 1 Janssen Research & Development, LLC $6,024.00 04/23/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272984
Principal investigator 1 Janssen Research & Development, LLC $2,150.00 03/21/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272728
Principal investigator 1 Janssen Research & Development, LLC $6,202.00 02/19/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175273089
Principal investigator 1 Novartis Pharmaceuticals Corporation $3,141.60 01/30/2025 Non-covered Recipient Entity
METRO KNOXVILLE HMA LLC TENNOVA HEALTHCARE TURKKEY CREEK MEDICAL CENTER
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190303251
Principal investigator 1 Abbott Laboratories $1,479.00 01/29/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248145916
Principal investigator 1 Abbott Laboratories $200.00 01/27/2025 Non-covered Recipient Entity
Tennova Healthcare-Turkey Creek Medical Center
NCT04226547--Amplatzer Amulet LAAO vs. NOAC No dispute reported 06/30/2026 1248145914
Principal investigator 1 Janssen Research & Development, LLC $12,333.00 01/22/2025 Non-covered Recipient Entity
Metro Knoxville Hma, Llc DBA Tennova Hlthcare - Tu
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175272996